salvage therapy

You have access
Impact of Long-term Adjuvant Hormonal Therapy in High-dose IMRT for Unfavorable Locally Advanced Prostate Cancer
TAKASHI OGATA, RIHITO AIZAWA, KIYONAO NAKAMURA, TAKASHI KOBAYASHI, SHUSUKE AKAMATSU, EIJIRO NAKAMURA, OSAMU OGAWA and TAKASHI MIZOWAKI

Anticancer Research August 2023, 43 (8) 3589-3596; DOI: https://doi.org/10.21873/anticanres.16538
You have access
Salvage Therapy After Regorafenib or Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer: A Conditional Landmark Analysis
MASAYUKI NAKASHIMA, MASATO TAKEUCHI, SHIRO TANAKA and KOJI KAWAKAMI

Anticancer Research February 2021, 41 (2) 1055-1062; DOI: https://doi.org/10.21873/anticanres.14862
You have access
Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy
GOKOULAKRICHENANE LOGANADANE, BENJAMIN H. KANN, HENRY S. PARK, SKYLER B. JOHNSON, SARAL MEHRA, BENJAMIN L. JUDSON, AARTI BHATIA, YAZID BELKACEMI, WENDELL G. YARBROUGH, BARBARA BURTNESS and ZAIN A. HUSAIN

Anticancer Research September 2019, 39 (9) 4885-4890; DOI: https://doi.org/10.21873/anticanres.13674
You have access
Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer
SEO HEE CHOI, JEE SUK CHANG, JINHYUN CHOI, SO HYUN PARK, KI CHANG KEUM, KYUNG RAN PARK and CHANG GEOL LEE

Anticancer Research May 2018, 38 (5) 3165-3173;
You have access
Identification and Management of Head and Neck Cancer Recurrences Detected on Adjuvant Radiation Oncology Simulation Scans
RICHARD L. BAKST and WILLIAM SU

Anticancer Research January 2017, 37 (1) 229-232;
You have access
Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer–Analysis of 1,678 Cases
MORTEN EBBE BOYSEN, ULF KAARE ZÄTTERSTRÖM and JAN FOLKVARD EVENSEN

Anticancer Research June 2016, 36 (6) 2849-2854;
You have access
Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience
TOMOYUKI MAKINO, HIROYUKI KONAKA and MIKIO NAMIKI

Anticancer Research January 2016, 36 (1) 313-317;
You have access
⁹⁰Y-Ibritumomab Tiuxetan Consolidation After Autologous Stem Cell Transplantation Improves Survival of Patients with Intermediate-/High-risk Diffuse Large B-cell Lymphoma Not Responding Adequately to First-line Treatment
PATRIZIA MONDELLO, VINCENZO PITINI, CARMELA ARRIGO, ENRICO DERENZINI and MICHAEL MIAN

Anticancer Research September 2014, 34 (9) 5121-5125;

Main menu

User menu

Search

salvage therapy